Brief: Medigene completes recruitment for Phase I/II DC vaccine trial in AML

Medigene AG

27/11/2017 06:30

Nov 27 (Reuters) - Medigene AG  MDG1k.DE : 
    * PTA-NEWS: MEDIGENE AG: PATIENT RECRUITMENT COMPLETED FOR 
PHASE 
I/II DC VACCINE TRIAL IN AML 
    * COMPLETION OF STUDY, AS PREVIOUSLY ANNOUNCED, IS EXPECTED 
IN 
2019 AFTER A TREATMENT PERIOD OF TWO YEARS FOR ALL PATIENTS 
 
Source text for Eikon:  ID:nPexb3r6ja  
Further company coverage:  MDG1k.DE  
 
 ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;))